SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-003292
Filing Date
2022-01-24
Accepted
2022-01-24 14:30:21
Documents
14
Period of Report
2022-01-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154427-8k_alkido.htm   iXBRL 8-K 26561
2 PRESS RELEASE, DATED JANUARY 24, 2022 ea154427ex99-1_aikido.htm EX-99.1 7689
3 GRAPHIC image_001.jpg GRAPHIC 5262
  Complete submission text file 0001213900-22-003292.txt   216451

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20220121.xsd EX-101.SCH 3054
5 XBRL LABEL FILE aiki-20220121_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE aiki-20220121_pre.xml EX-101.PRE 22609
8 EXTRACTED XBRL INSTANCE DOCUMENT ea154427-8k_alkido_htm.xml XML 3495
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 22548868
SIC: 8731 Services-Commercial Physical & Biological Research